We are seeking to build a team who share our vision and are passionate about the conversion of groundbreaking science into therapies.
The Milner Therapeutics Institute is part of the School of Biological Sciences and the School of Clinical Medicine at the University of Cambridge and is dedicated to the conversion of ground breaking science into therapies. It is currently based at the Gurdon Institute and will move into new purpose built drug discovery laboratories on the Cambridge Biomedical Campus in October 2018. The Institute is surrounded by a global therapeutic alliance of 65 SMEs, pharma companies, academic institutions and venture capital firms. The drug discovery research group at the Milner will be working on pre-competitive projects in collaboration with pharmaceutical companies and its own drug discovery portfolio.
We are not currently advertising for new positions. Please check back soon.